Johnson & Johnson halts mid-stage trial of experimental eczema drug
Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg |…
Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill…
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker…
UnitedHealth Group releases results of independent audit
UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans |…
Food brands chase fibermaxxing trend with new high-fiber products
Workers are suspended on a Pepsi sign on a building outside of Allegiant Stadium ahead of LVIII in…
Eli Lilly to build $6 billion Alabama manufacturing plant
Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept.…
Novo Nordisk shares plunge after Alzheimer’s drug trial fails to hit key target
The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. Nichlas Pollier | Bloomberg |…
Novo Nordisk cuts cash prices for Wegovy, Ozempic
Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024.…
WeightWatchers to offer Novo Nordisk’s Wegovy pill after 2026 launch
Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg |…
U.S. employer health plans tap prescriptions that feds say are illegal
Every step is a struggle for Bruce Zimmerman, whose health has been deteriorating since he was diagnosed with…